Bora Biologics Completes 2,000L Engineering Run in San Diego

Successful scale-up reinforces company's commercial-scale readiness.

Apr. 6, 2026 at 3:00pm

Got story updates? Submit your updates here. ›

Bora Biologics, a biopharmaceutical company, has successfully completed its first 2,000-liter engineering, scale-up, and process confirmation run at its FDA-approved facility in San Diego. This milestone follows the company's recent $30 million expansion and marks a key step in its commercial-scale readiness.

Why it matters

The successful completion of this large-scale engineering run demonstrates Bora Biologics' ability to operate at the commercial scale required by its pharmaceutical clients. As the industry prioritizes partners who are already producing at scale, this achievement positions Bora Biologics as a reliable and capable supplier.

The details

The 2,000-liter engineering run was conducted at Bora Biologics' FDA-approved facility in San Diego. This milestone follows the company's recent $30 million expansion, which has enabled it to enhance its production capabilities and meet the growing demand from its pharmaceutical clients.

  • Bora Biologics completed the 2,000-liter engineering run on April 6, 2026.

The players

Bora Biologics

A biopharmaceutical company that specializes in the development and manufacturing of biologics.

Got photos? Submit your photos here. ›

The takeaway

Bora Biologics' successful completion of the 2,000-liter engineering run demonstrates its ability to operate at the commercial scale required by the pharmaceutical industry, positioning the company as a reliable and capable supplier.